| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 119.711 | 154.526 | 162.253 | 152.477 | 126.455 | 75.379 | 83.093 | 130.177 | 103.421 | 98.844 |
| Total Income - EUR | 119.711 | 154.881 | 163.342 | 152.477 | 126.455 | 78.687 | 83.504 | 133.279 | 105.091 | 101.397 |
| Total Expenses - EUR | 119.256 | 155.761 | 163.290 | 151.796 | 126.507 | 77.982 | 90.302 | 132.509 | 110.221 | 108.555 |
| Gross Profit/Loss - EUR | 455 | -880 | 52 | 680 | -52 | 706 | -6.797 | 769 | -5.130 | -7.158 |
| Net Profit/Loss - EUR | 292 | -880 | 52 | 315 | -52 | 108 | -7.628 | -534 | -6.181 | -7.158 |
| Employees | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Valeximona Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 812 | 91 | 0 | 0 | 0 | 0 | 578 | 508 | 435 | 362 |
| Current Assets | 12.563 | 20.618 | 12.769 | 18.099 | 13.096 | 13.236 | 14.830 | 14.462 | 19.897 | 12.229 |
| Inventories | 10.609 | 16.175 | 8.428 | 11.940 | 12.797 | 12.075 | 13.463 | 8.712 | 12.679 | 10.272 |
| Receivables | 1.259 | 1.299 | 781 | 353 | 120 | 118 | 417 | 1.043 | 605 | 243 |
| Cash | 694 | 3.145 | 3.561 | 5.806 | 178 | 1.042 | 951 | 4.706 | 6.613 | 1.714 |
| Shareholders Funds | 4.661 | -827 | 9.083 | 9.198 | 8.544 | 8.490 | 510 | -22 | -6.818 | -13.939 |
| Social Capital | 45 | 45 | 9.895 | 9.713 | 9.525 | 9.344 | 9.137 | 9.166 | 9.138 | 9.087 |
| Debts | 8.713 | 21.723 | 3.719 | 8.901 | 4.796 | 4.745 | 14.898 | 14.991 | 27.513 | 27.022 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4636 - 4636" | |||||||||
| CAEN Financial Year |
4636
|
|||||||||
Comments - Valeximona Srl